speb/financial-data huggingface dataset:
FCNCP cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -280000000.00
FCNCP balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 21700000000.00
FCNCP balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 3560000000.00
FCNCP balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 3560000000.00
FCNCP income_statement (quarterly, 2025-06-30) — Normalized Income: 597770000.00
FCNCP income_statement (quarterly, 2025-06-30) — Occupancy And Equipment: 192000000.00
FCNCP cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 859000000.00
FCNCP cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -9000000.00
FCNCP income_statement (quarterly, 2025-06-30) — Operating Revenue: 2302000000.00
FCNCP balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 13075979.00
FCNCP balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -114000000.00
FCNCP balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 250000000.00
FCNCP cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 58000000.00
FCNCP income_statement (quarterly, 2025-06-30) — Other Non Interest Expense: 129000000.00
FCNCP balance_sheet (quarterly, 2025-06-30) — Other Properties: 11899000000.00
FCNCP balance_sheet (quarterly, 2025-06-30) — Other Receivables: 5284000000.00
FCNCP balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 10310000000.00
FCNCP income_statement (quarterly, 2025-06-30) — Other Special Charges: -8000000.00
FCNCP balance_sheet (quarterly, 2025-06-30) — Payables: 120000000.00
FCNCP balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 120000000.00
FCNCP balance_sheet (quarterly, 2025-06-30) — Preferred Shares Number: 8345000.00
FCNCP balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 881000000.00
FCNCP income_statement (quarterly, 2025-06-30) — Preferred Stock Dividends: 14000000.00
FCNCP balance_sheet (quarterly, 2025-06-30) — Preferred Stock Equity: 881000000.00
FCNCP income_statement (quarterly, 2025-06-30) — Pretax Income: 758000000.00
FCNCP income_statement (quarterly, 2025-06-30) — Professional Expense And Contract Services Expense: 30000000.00
FCNCP cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -1056000000.00
FCNCP cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -341000000.00
FCNCP balance_sheet (quarterly, 2025-06-30) — Receivables: 6186000000.00
FCNCP income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 100000000.00
FCNCP income_statement (quarterly, 2025-06-30) — Rent And Landing Fees: 55000000.00
FCNCP income_statement (quarterly, 2025-06-30) — Rent Expense Supplemental: 55000000.00
FCNCP cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -351000000.00
FCNCP cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -613000000.00
FCNCP income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 38000000.00
FCNCP balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 20337000000.00
FCNCP income_statement (quarterly, 2025-06-30) — Salaries And Wages: 810000000.00
FCNCP cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 2221000000.00
FCNCP cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 61000000.00
FCNCP income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 32000000.00
FCNCP income_statement (quarterly, 2025-06-30) — Selling General And Administration: 935000000.00
FCNCP balance_sheet (quarterly, 2025-06-30) — Share Issued: 13075979.00
FCNCP income_statement (quarterly, 2025-06-30) — Special Income Charges: -30000000.00
FCNCP balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 22296000000.00
FCNCP balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 20819000000.00
FCNCP income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -7230000.00
FCNCP income_statement (quarterly, 2025-06-30) — Tax Provision: 183000000.00
FCNCP income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.24
FCNCP balance_sheet (quarterly, 2025-06-30) — Total Assets: 229653000000.00
FCNCP balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 59874000000.00
FCNCP balance_sheet (quarterly, 2025-06-30) — Total Debt: 37997000000.00
FCNCP balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 22296000000.00
FCNCP balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 207357000000.00
FCNCP income_statement (quarterly, 2025-06-30) — Total Unusual Items: -30000000.00
FCNCP income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -30000000.00
FCNCP cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: -2000000.00
FCNCP income_statement (quarterly, 2025-09-30) — +Total Revenue: 2430000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 105000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 945000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 270000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Amortization: 13000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Amortization Of Intangibles Income Statement: 13000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 0.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 22510000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 889000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -375000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 408000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Capital Stock: 894000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 25672000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Federal Funds Sold: 25755000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -39000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Cash Financial: 874000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 2870000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -3801000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 916000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 155000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -55000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 100000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Changes In Cash: -15000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Common Stock: 13000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 21105000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -896000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -30000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Deferred Tax: -30000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Defined Pension Benefit: 670000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 91000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 111000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 91000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 111000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 98000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 520000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 554000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 825000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — End Cash Position: 874000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 2870000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 541000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: -4000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 13000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -44000000.00
FCNCP income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 922000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Goodwill: 346000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 584000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Gross PPE: 12034000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Held To Maturity Securities: 9546000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 118000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Insurance And Claims: 38000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Interest Expense: 1264000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Interest Income: 2998000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 1241000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Invested Capital: 59290000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -3801000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 45284000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 597000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 408000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 38185000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 38593000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 597000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -3000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 265000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -896000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Net Debt: 12513000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Net Income: 568000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 554000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 568000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 568000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 568000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 568000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 568000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Net Interest Income: 1734000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -1591000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 594000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 594000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 0.00
FCNCP cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 84000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Net PPE: 12034000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -304000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 21402000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 3580000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 3580000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Normalized Income: 586900000.00
FCNCP income_statement (quarterly, 2025-09-30) — Occupancy And Equipment: 195000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 916000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -12000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Operating Revenue: 2430000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 12618629.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -44000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 238000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 21000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Other Non Interest Expense: 176000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Other Properties: 12034000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Other Receivables: 5533000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 13228000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Other Special Charges: -3000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Payables: 105000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 105000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Preferred Shares Number: 8345000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 881000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Preferred Stock Dividends: 14000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 881000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Pretax Income: 751000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Professional Expense And Contract Services Expense: 26000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -4737000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -375000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Receivables: 6478000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 91000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Rent And Landing Fees: 67000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Rent Expense Supplemental: 67000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -3000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -896000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 28000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 20866000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Salaries And Wages: 817000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 3146000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 71000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 33000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Selling General And Administration: 955000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Share Issued: 12618629.00
FCNCP income_statement (quarterly, 2025-09-30) — Special Income Charges: -25000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 21986000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 20521000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -6100000.00
FCNCP income_statement (quarterly, 2025-09-30) — Tax Provision: 183000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.24
FCNCP balance_sheet (quarterly, 2025-09-30) — Total Assets: 233488000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 60171000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Total Debt: 38593000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 21986000000.00
FCNCP balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 211502000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Total Unusual Items: -25000000.00
FCNCP income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -25000000.00
FCNCP cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: -13000000.00
FCNCP income_statement (annual, 2025-12-31) — +Total Revenue: 9252000000.00
FCNCP income_statement (quarterly, 2025-12-31) — +Total Revenue: 2164000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Accounts Payable: 140000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 140000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Accounts Receivable: 912000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 912000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -1903000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -1903000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 0.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 0.00
FCNCP income_statement (annual, 2025-12-31) — Amortization: 54000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Amortization: 13000000.00
FCNCP income_statement (annual, 2025-12-31) — Amortization Of Intangibles Income Statement: 54000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Amortization Of Intangibles Income Statement: 13000000.00
FCNCP cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 6000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 1000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 3249000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 3249000000.00
FCNCP cash_flow (annual, 2025-12-31) — Beginning Cash Position: 814000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 874000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 1808000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 1808000000.00
FCNCP cash_flow (annual, 2025-12-31) — Capital Expenditure: -1562000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -573000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 401000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 401000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Capital Stock: 1387000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1387000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 20602000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 20602000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 20834000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 20834000000.00
FCNCP cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -161000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -40000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Cash Financial: 801000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Cash Financial: 801000000.00
FCNCP cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 2675000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -4752000000.00
FCNCP cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -5611000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 3629000000.00
FCNCP cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 2923000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 1050000000.00
FCNCP cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -282000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -196000000.00
FCNCP cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 170000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 515000000.00
FCNCP cash_flow (annual, 2025-12-31) — Change In Working Capital: -112000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 319000000.00
FCNCP cash_flow (annual, 2025-12-31) — Changes In Cash: -13000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Changes In Cash: -73000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Common Stock: 12000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Common Stock: 12000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Common Stock Equity: 20863000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 20863000000.00
FCNCP cash_flow (annual, 2025-12-31) — Common Stock Payments: -3027000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -900000000.00
FCNCP cash_flow (annual, 2025-12-31) — Deferred Income Tax: -111000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -7000000.00
FCNCP cash_flow (annual, 2025-12-31) — Deferred Tax: -111000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Deferred Tax: -7000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Defined Pension Benefit: 784000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Defined Pension Benefit: 784000000.00
FCNCP cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 405000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 121000000.00
FCNCP income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 452000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 115000000.00
FCNCP cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 405000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 121000000.00
FCNCP income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 452000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 115000000.00
FCNCP income_statement (annual, 2025-12-31) — Depreciation Income Statement: 398000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 102000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 494000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 494000000.00
FCNCP income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 2149000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 566000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Employee Benefits: 1042000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 1042000000.00
FCNCP cash_flow (annual, 2025-12-31) — End Cash Position: 801000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — End Cash Position: 801000000.00
FCNCP cash_flow (annual, 2025-12-31) — Financing Cash Flow: 2675000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -4752000000.00
FCNCP cash_flow (annual, 2025-12-31) — Free Cash Flow: 1361000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 477000000.00
FCNCP cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -3000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -3000000.00
FCNCP cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: -32000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: -15000000.00
FCNCP income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 25000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 15000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 83000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 83000000.00
FCNCP income_statement (annual, 2025-12-31) — General And Administrative Expense: 3679000000.00
FCNCP income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 940000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Goodwill: 346000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Goodwill: 346000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 573000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 573000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Gross PPE: 14265000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Gross PPE: 14265000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Held To Maturity Securities: 9647000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Held To Maturity Securities: 9647000000.00
FCNCP cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 315000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 26000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Income Tax Payable: 3819000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 3819000000.00
FCNCP income_statement (annual, 2025-12-31) — Insurance And Claims: 141000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Insurance And Claims: 27000000.00
FCNCP income_statement (annual, 2025-12-31) — Interest Expense: 4964000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Interest Expense: 1218000000.00
FCNCP income_statement (annual, 2025-12-31) — Interest Income: 11778000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Interest Income: 2940000000.00
FCNCP cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 4810000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 1147000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Invested Capital: 56575000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Invested Capital: 56575000000.00
FCNCP cash_flow (annual, 2025-12-31) — Investing Cash Flow: -5611000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 3629000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Investments And Advances: 44686000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 44686000000.00
FCNCP cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 494000000.00
FCNCP cash_flow (annual, 2025-12-31) — Issuance Of Debt: 1838000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: -1000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Land And Improvements: 496000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 496000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 401000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 401000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Long Term Debt: 35712000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 35712000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 36113000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 36113000000.00
FCNCP cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 1838000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: -1000000.00
FCNCP cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -2850000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -2495000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Long Term Provisions: 260000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 260000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 2046000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 2046000000.00
FCNCP cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 0.00
FCNCP cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -3027000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -900000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Net Debt: 15110000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Net Debt: 15110000000.00
FCNCP income_statement (annual, 2025-12-31) — Net Income: 2206000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Net Income: 580000000.00
FCNCP income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 2149000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 566000000.00
FCNCP income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 2206000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 580000000.00
FCNCP income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 2206000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 580000000.00
FCNCP income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 2206000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 580000000.00
FCNCP cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 2206000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 580000000.00
FCNCP income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 2206000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 580000000.00
FCNCP income_statement (annual, 2025-12-31) — Net Interest Income: 6814000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Net Interest Income: 1722000000.00
FCNCP cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 3454000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 3723000000.00
FCNCP cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -1012000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -2496000000.00
FCNCP cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -1012000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -2496000000.00
FCNCP cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -565000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -514000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Net PPE: 12362000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Net PPE: 12362000000.00
FCNCP cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -1277000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -483000000.00
FCNCP cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: 494000000.00
FCNCP cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 0.00
FCNCP balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 21665000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 21665000000.00
FCNCP income_statement (annual, 2025-12-31) — Normalized Income: 2295160000.00
FCNCP income_statement (quarterly, 2025-12-31) — Normalized Income: 600024660.91
FCNCP income_statement (annual, 2025-12-31) — Occupancy And Equipment: 793000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Occupancy And Equipment: 212000000.00
FCNCP cash_flow (annual, 2025-12-31) — Operating Cash Flow: 2923000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 1050000000.00
FCNCP cash_flow (annual, 2025-12-31) — Operating Gains Losses: -47000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -18000000.00
FCNCP income_statement (annual, 2025-12-31) — Operating Revenue: 9252000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Operating Revenue: 2164000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 12139159.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 12139159.00
FCNCP balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 83000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 83000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 227000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 227000000.00
FCNCP cash_flow (annual, 2025-12-31) — Other Non Cash Items: 84000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 12000000.00
FCNCP income_statement (annual, 2025-12-31) — Other Non Interest Expense: 466000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Other Non Interest Expense: -75000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Other Properties: 9915000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Other Properties: 9915000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Other Receivables: 634000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Other Receivables: 634000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 31790000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 31790000000.00
FCNCP income_statement (annual, 2025-12-31) — Other Special Charges: -30000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Other Special Charges: -14000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Payables: 3959000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Payables: 3959000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 3959000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 3959000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Preferred Shares Number: 8345000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Preferred Shares Number: 8345000.00
FCNCP balance_sheet (annual, 2025-12-31) — Preferred Stock: 1375000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 1375000000.00
FCNCP income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 57000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Preferred Stock Dividends: 14000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 1375000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 1375000000.00
FCNCP cash_flow (annual, 2025-12-31) — Preferred Stock Issuance: 494000000.00
FCNCP income_statement (annual, 2025-12-31) — Pretax Income: 2971000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Pretax Income: 811000000.00
FCNCP income_statement (annual, 2025-12-31) — Professional Expense And Contract Services Expense: 115000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Professional Expense And Contract Services Expense: 34000000.00
FCNCP cash_flow (annual, 2025-12-31) — Purchase Of Investment: -14363000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -6498000000.00
FCNCP cash_flow (annual, 2025-12-31) — Purchase Of PPE: -1562000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -573000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Receivables: 1546000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Receivables: 1546000000.00
FCNCP income_statement (annual, 2025-12-31) — Reconciled Depreciation: 405000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 121000000.00
FCNCP income_statement (annual, 2025-12-31) — Rent And Landing Fees: 244000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Rent And Landing Fees: 64000000.00
FCNCP income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 244000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Rent Expense Supplemental: 64000000.00
FCNCP cash_flow (annual, 2025-12-31) — Repayment Of Debt: -2850000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -2495000000.00
FCNCP cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -3027000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -900000000.00
FCNCP income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 141000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 33000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Retained Earnings: 20768000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 20768000000.00
FCNCP income_statement (annual, 2025-12-31) — Salaries And Wages: 3294000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Salaries And Wages: 849000000.00
FCNCP cash_flow (annual, 2025-12-31) — Sale Of Business: 0.00
FCNCP cash_flow (annual, 2025-12-31) — Sale Of Investment: 17817000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 10221000000.00
FCNCP cash_flow (annual, 2025-12-31) — Sale Of PPE: 285000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 90000000.00
FCNCP income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 142000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 45000000.00
FCNCP income_statement (annual, 2025-12-31) — Selling General And Administration: 3821000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Selling General And Administration: 985000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Share Issued: 12139159.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Share Issued: 12139159.00
FCNCP cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 0.00
FCNCP cash_flow (annual, 2025-12-31) — Short Term Debt Payments: 0.00
FCNCP income_statement (annual, 2025-12-31) — Special Income Charges: -120000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Special Income Charges: -28000000.00
FCNCP cash_flow (annual, 2025-12-31) — Stock Based Compensation: 0.00
FCNCP balance_sheet (annual, 2025-12-31) — Stockholders Equity: 22238000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 22238000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Tangible Book Value: 20290000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 20290000000.00
FCNCP income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -30840000.00
FCNCP income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -7975339.09
FCNCP income_statement (annual, 2025-12-31) — Tax Provision: 765000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Tax Provision: 231000000.00
FCNCP income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.26
FCNCP income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.28
FCNCP balance_sheet (annual, 2025-12-31) — Total Assets: 229698000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Total Assets: 229698000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Total Capitalization: 57950000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 57950000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Total Debt: 36113000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Total Debt: 36113000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 22238000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 22238000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 207460000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 207460000000.00
FCNCP balance_sheet (annual, 2025-12-31) — Total Tax Payable: 3819000000.00
FCNCP balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 3819000000.00
FCNCP income_statement (annual, 2025-12-31) — Total Unusual Items: -120000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Total Unusual Items: -28000000.00
FCNCP income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -120000000.00
FCNCP income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -28000000.00
FCNCP cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -22000000.00
FCNCP cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -12000000.00
FCNCP income_statement (quarterly, 2026-03-31) — +Total Revenue: 2310000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 109000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 955000000.00
FCNCP income_statement (quarterly, 2026-03-31) — Amortization: 13000000.00
FCNCP income_statement (quarterly, 2026-03-31) — Amortization Of Intangibles Income Statement: 13000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 0.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 3203000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 801000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -335000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 390000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1777000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 24269000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Federal Funds Sold: 24492000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -51000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Cash Financial: 1080000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 6644000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -6537000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 172000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -103000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -680000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -783000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Changes In Cash: 279000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Common Stock: 12000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 20283000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -899000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 8000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Deferred Tax: 8000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Defined Pension Benefit: 794000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 180000000.00
FCNCP income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 114000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 180000000.00
FCNCP income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 114000000.00
FCNCP income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 101000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 448000000.00
FCNCP income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 508000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Employee Benefits: 519000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — End Cash Position: 1080000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 6644000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -163000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: -11000000.00
FCNCP income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 3000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -72000000.00
FCNCP income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 972000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Goodwill: 346000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 561000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Gross PPE: 12469000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Held To Maturity Securities: 9542000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 51000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 3825000000.00
FCNCP income_statement (quarterly, 2026-03-31) — Insurance And Claims: 38000000.00
FCNCP income_statement (quarterly, 2026-03-31) — Interest Expense: 1165000000.00
FCNCP income_statement (quarterly, 2026-03-31) — Interest Income: 2786000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 1161000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Invested Capital: 54002000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -6537000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 46059000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 390000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 497000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 390000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 33719000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 34109000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 497000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -2503000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 228000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -899000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Net Debt: 9450000000.00
FCNCP income_statement (quarterly, 2026-03-31) — Net Income: 534000000.00
FCNCP income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 508000000.00
FCNCP income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 534000000.00
FCNCP income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 534000000.00
FCNCP income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 534000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 534000000.00
FCNCP income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 534000000.00
FCNCP income_statement (quarterly, 2026-03-31) — Net Interest Income: 1621000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -1557000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -2006000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -2006000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -42000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Net PPE: 12469000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -280000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Net Preferred Stock Issuance: 390000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 21487000000.00
FCNCP income_statement (quarterly, 2026-03-31) — Normalized Income: 535514000.00
FCNCP income_statement (quarterly, 2026-03-31) — Occupancy And Equipment: 196000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 172000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -8000000.00
FCNCP income_statement (quarterly, 2026-03-31) — Operating Revenue: 2310000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 11689314.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -72000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 215000000.00
FCNCP cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 172000000.00
FCNCP income_statement (quarterly, 2026-03-31) — Other Non Interest Expense: 195000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Other Properties: 12469000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Other Receivables: 628000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 33314000000.00
FCNCP income_statement (quarterly, 2026-03-31) — Other Special Charges: -11000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Payables: 3934000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 3934000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Preferred Shares Number: 24345000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 1765000000.00
FCNCP income_statement (quarterly, 2026-03-31) — Preferred Stock Dividends: 26000000.00
FCNCP balance_sheet (quarterly, 2026-03-31) — Preferred Stock Equity: 1765000000.00